EnXray
2012
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Later Stage VC
LATEST DEAL TYPE
$324K
LATEST DEAL AMOUNT
6
INVESTORS
Description
Developer of radiation sterilization equipment for generation of low energy X-rays. The company's Low Energy X-ray technology has the unique capability of generating lower energy X-rays in the range of 8-30 keV for sterilization of medical devices and life science products, enabling manufacturers of medical devices to sterilize their products on site and on demand to the international regulatory standards - streamlining products, improving quality & efficiency and reducing costs.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Electrical Equipment
Other Industries
Biotechnology
Primary Office
- Liverpool Innovation Park
- Edge Lane
- Liverpool L7 9NJ
- England, United Kingdom
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore EnXray’s full profile, request a free trial.
EnXray Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 18-May-2018 | $324K | 00.000 | 00.000 | Completed | Generating Revenue |
| 4. Early Stage VC (Series B) | 03-Mar-2017 | 00.000 | 00.00 | 00.000 | Completed | Startup |
| 3. Grant | 12-Dec-2016 | 000.00 | 00.000 | Completed | Startup | |
| 2. Debt - General | $3.89M | $4.53M | Completed | Startup | ||
| 1. Early Stage VC | 05-Mar-2014 | $1.93M | $1.93M | 00.000 | Completed | Startup |
EnXray Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 000 | 00.000000 | 000.0 | 000.0 | 00 | 000.0 | 0.000 | |
| A Ordinary | 00,000 | 00.000000 | 000.0 | 000.0 | 00 | 000.0 | 0.000 | |
| A Ordinary | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| Ordinary | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.00 | |
| A Ordinary | 13,537 | $0.013693 | $18.48 | $18.48 | 1x | $18.48 | 3.42% | |
| A Ordinary | 58,876 | $0.013693 | $20.54 | $20.54 | 1x | $20.54 | 14.89% |
EnXray Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| CBC Holdings | Other | Minority | 000 0000 | 000000 0 | ||
| Horizon 2020 | Government | 000 0000 | 000000 0 | |||
| SMS Electronics | Corporation | Minority | 000 0000 | 000000 0 | ||
| Spark Impact | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| The North West Fund | Venture Capital | Minority | 000 0000 | 000000 0 |
EnXray Executive Team (4)
EnXray Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Edward Cappabianca | EnXray | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Julie Rasmussen | Self | Board Member | 000 0000 | |
| Marc D'Abbadie Ph.D | Spark Impact | Board Member | 000 0000 | |
| Renee Julie Elisabeth Aguiar-Lucander | Self | Chairman | 000 0000 | |
| Yuri Udalov | EnXray | Chief Technology Officer & Board Member | 000 0000 |